Literature DB >> 11161178

Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT.

C Cuenod1, I Leconte, N Siauve, A Resten, C Dromain, B Poulet, F Frouin, O Clément, G Frija.   

Abstract

PURPOSE: To determine whether computed tomography (CT) can depict liver hemodynamic changes caused by occult hepatic micrometastases in rat.
MATERIALS AND METHODS: Liver micrometastases (mean diameter, 500 micrometer +/- 300) were produced in seven BD IX rats by injecting 10(7) DHDK12 PROb colorectal carcinoma cells into the spleen. Macrometastases (mean diameter, 7 mm +/- 3) were produced in four other rats. Five normal rats were studied as controls. CT images were obtained every 300 msec for 30 seconds during the injection of 1 mL per kilogram of body weight of contrast medium. The time-attenuation curves of the aorta, portal vein, and liver were used to calculate liver perfusion with a deconvolution model designed for the dual blood supply.
RESULTS: Micrometastases in an apparently normal liver caused a 34% decrease in portal blood flow and a 25% increase in the mean transit time for the blood to pass through the liver. These findings suggest increased resistance in the sinusoidal capillaries. Similar but greater changes were found in the macrometastases.
CONCLUSION: Occult liver micrometastases in rats generate changes in liver perfusion that can be detected with CT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161178     DOI: 10.1148/radiology.218.2.r01fe10556

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  40 in total

1.  Hepatic computed tomography perfusion: comparison of maximum slope and dual-input single-compartment methods.

Authors:  Tomonori Kanda; Takeshi Yoshikawa; Yoshiharu Ohno; Naoki Kanata; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

Review 2.  Clinical application of hepatic CT perfusion.

Authors:  Liang Zhong; Wen-Jing Wang; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

3.  Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.

Authors:  Michael A Fischer; Katharina Brehmer; Anders Svensson; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

4.  Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study.

Authors:  Q Wang; G Shi; L Wang; X Liu; R Wu
Journal:  Br J Radiol       Date:  2014-01-27       Impact factor: 3.039

Review 5.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

6.  Stereological quantification of microvessels using semiautomated evaluation of X-ray microtomography of hepatic vascular corrosion casts.

Authors:  Miroslav Jiřík; Zbyněk Tonar; Anna Králíčková; Lada Eberlová; Hynek Mírka; Petra Kochová; Tomáš Gregor; Petr Hošek; Miroslava Svobodová; Eduard Rohan; Milena Králíčková; Václav Liška
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-03-23       Impact factor: 2.924

Review 7.  Perfusion magnetic resonance imaging of the liver.

Authors:  Choon Hua Thng; Tong San Koh; David J Collins; Dow Mu Koh
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

8.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

9.  Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.

Authors:  Keiko Miyazaki; David J Collins; Simon Walker-Samuel; Jane N Taylor; Anwar R Padhani; Martin O Leach; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

Review 10.  Colorectal cancer: imaging surveillance following resection of primary tumour.

Authors:  Ken Miles; Guy Burkill
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.